BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 17317843)

  • 1. DNA mismatch repair initiates 6-thioguanine--induced autophagy through p53 activation in human tumor cells.
    Zeng X; Yan T; Schupp JE; Seo Y; Kinsella TJ
    Clin Cancer Res; 2007 Feb; 13(4):1315-21. PubMed ID: 17317843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel role for DNA mismatch repair and the autophagic processing of chemotherapy drugs in human tumor cells.
    Zeng X; Kinsella TJ
    Autophagy; 2007; 3(4):368-70. PubMed ID: 17426439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BNIP3 is essential for mediating 6-thioguanine- and 5-fluorouracil-induced autophagy following DNA mismatch repair processing.
    Zeng X; Kinsella TJ
    Cell Res; 2010 Jun; 20(6):665-75. PubMed ID: 20368736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA mismatch repair (MMR) mediates 6-thioguanine genotoxicity by introducing single-strand breaks to signal a G2-M arrest in MMR-proficient RKO cells.
    Yan T; Berry SE; Desai AB; Kinsella TJ
    Clin Cancer Res; 2003 Jun; 9(6):2327-34. PubMed ID: 12796402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interdependence of DNA mismatch repair proteins MLH1 and MSH2 in apoptosis in human colorectal carcinoma cell lines.
    Hassen S; Ali AA; Kilaparty SP; Al-Anbaky QA; Majeed W; Boman BM; Fields JZ; Ali N
    Mol Cell Biochem; 2016 Jan; 412(1-2):297-305. PubMed ID: 26728996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defective expression of the DNA mismatch repair protein, MLH1, alters G2-M cell cycle checkpoint arrest following ionizing radiation.
    Davis TW; Wilson-Van Patten C; Meyers M; Kunugi KA; Cuthill S; Reznikoff C; Garces C; Boland CR; Kinsella TJ; Fishel R; Boothman DA
    Cancer Res; 1998 Feb; 58(4):767-78. PubMed ID: 9485033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective radiosensitization of drug-resistant MutS homologue-2 (MSH2) mismatch repair-deficient cells by halogenated thymidine (dThd) analogues: Msh2 mediates dThd analogue DNA levels and the differential cytotoxicity and cell cycle effects of the dThd analogues and 6-thioguanine.
    Berry SE; Davis TW; Schupp JE; Hwang HS; de Wind N; Kinsella TJ
    Cancer Res; 2000 Oct; 60(20):5773-80. PubMed ID: 11059773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mammalian target of rapamycin and S6 kinase 1 positively regulate 6-thioguanine-induced autophagy.
    Zeng X; Kinsella TJ
    Cancer Res; 2008 Apr; 68(7):2384-90. PubMed ID: 18381446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BRCA1 activates a G2-M cell cycle checkpoint following 6-thioguanine-induced DNA mismatch damage.
    Yamane K; Schupp JE; Kinsella TJ
    Cancer Res; 2007 Jul; 67(13):6286-92. PubMed ID: 17616687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of DNA mismatch repair imparts defective cdc2 signaling and G(2) arrest responses without altering survival after ionizing radiation.
    Yan T; Schupp JE; Hwang HS; Wagner MW; Berry SE; Strickfaden S; Veigl ML; Sedwick WD; Boothman DA; Kinsella TJ
    Cancer Res; 2001 Nov; 61(22):8290-7. PubMed ID: 11719462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential role of MLH1 in the induction of p53 and apoptosis by blocking transcription on damaged DNA templates.
    Yanamadala S; Ljungman M
    Mol Cancer Res; 2003 Aug; 1(10):747-54. PubMed ID: 12939400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P53 modulates the effect of loss of DNA mismatch repair on the sensitivity of human colon cancer cells to the cytotoxic and mutagenic effects of cisplatin.
    Lin X; Ramamurthi K; Mishima M; Kondo A; Christen RD; Howell SB
    Cancer Res; 2001 Feb; 61(4):1508-16. PubMed ID: 11245458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemistry of proteins for DNA mismatch repair in correlation to prognostic factors of mammarian cancer.
    Köster F; Schröer A; Fischer D; Horn AK; Diedrich K; Friedrich M
    Oncol Rep; 2007 May; 17(5):1223-7. PubMed ID: 17390069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myc down-regulation sensitizes melanoma cells to radiotherapy by inhibiting MLH1 and MSH2 mismatch repair proteins.
    Bucci B; D'Agnano I; Amendola D; Citti A; Raza GH; Miceli R; De Paula U; Marchese R; Albini S; Felsani A; Brunetti E; Vecchione A
    Clin Cancer Res; 2005 Apr; 11(7):2756-67. PubMed ID: 15814658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MLH1 expression sensitises ovarian cancer cells to cell death mediated by XIAP inhibition.
    Ding X; Mohd AB; Huang Z; Baba T; Bernardini MQ; Lyerly HK; Berchuck A; Murphy SK; Buermeyer AB; Devi GR
    Br J Cancer; 2009 Jul; 101(2):269-77. PubMed ID: 19603033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance to 6-thioguanine in mismatch repair-deficient human cancer cell lines correlates with an increase in induced mutations at the HPRT locus.
    Glaab WE; Risinger JI; Umar A; Barrett JC; Kunkel TA; Tindall KR
    Carcinogenesis; 1998 Nov; 19(11):1931-7. PubMed ID: 9855005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of p53 mutation and mismatch repair proteins dysregulation in NNK-induced malignant transformation of human bronchial epithelial cells.
    Shen Y; Zhang S; Huang X; Chen K; Shen J; Wang Z
    Biomed Res Int; 2014; 2014():920275. PubMed ID: 25215298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-repression of mismatch repair gene expression by hypoxia in cancer cells: role of the Myc/Max network.
    Bindra RS; Glazer PM
    Cancer Lett; 2007 Jul; 252(1):93-103. PubMed ID: 17275176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MLH1 function is context dependent in colorectal cancers.
    Jackson T; Ahmed MA; Seth R; Jackson D; Ilyas M
    J Clin Pathol; 2011 Feb; 64(2):141-5. PubMed ID: 21169277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of the DNA mismatch repair system in the cytotoxicity of the topoisomerase inhibitors camptothecin and etoposide to human colorectal cancer cells.
    Jacob S; Aguado M; Fallik D; Praz F
    Cancer Res; 2001 Sep; 61(17):6555-62. PubMed ID: 11522654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.